Discover life science companies in Aberdeen, including therapeutic developers, microbiology services and antibody specialists.
Custom recombinant antibody and protein development services
Scotia Biologics is a contract research organisation specialising in custom antibody and recombinant protein development for biomedical researchers and diagnostic developers. Services span antigen design, polyclonal and monoclonal antibody generation via hybridoma and phage display, antibody engineering including…
AI-driven antibody reagents and diagnostics for research and clinical use
Vertebrate Antibodies is a contract research organisation developing custom monoclonal antibodies, recombinant proteins, and AI-driven diagnostic products for research and clinical applications. Its AI-driven epitope prediction and antigen display platforms enable highly specific antibody generation against novel…
Microbiology services and UK national bacterial culture collection
NCIMB is a UK microbiology services company and custodian of the National Collection of Industrial, Food and Marine Bacteria, the UK's largest public bacterial culture collection with over 10,000 strains. The company provides GMP-compliant microbial identification, whole genome sequencing, microbial community…
Tau-targeting therapeutics and diagnostics for neurodegenerative disease
TauRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments and diagnostics for Alzheimer's disease and related neurodegenerative disorders. Its pipeline centres on tau aggregation inhibitors, which target the pathological accumulation of tau protein implicated in dementia. The company's…
Shark-derived single-domain antibody biologics for cancer and inflammation
Elasmogen is a biotechnology company developing next-generation therapeutic biologics based on its proprietary soloMER platform, single-domain antibody-like proteins derived from the shark immune system. soloMERs offer advantages over conventional antibodies in size, stability, and tissue penetration. The pipeline…
Clinical-stage anti-infectives targeting antimicrobial resistance and infectious disease
NovaBiotics is a clinical-stage biotechnology company developing first-in-class anti-infective therapies for difficult-to-treat infectious diseases, with a focus on antimicrobial resistance. Its pipeline is built on two proprietary platforms: an anti-infective peptide platform yielding antifungal and antibacterial…